LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has announced a delay in the dispatch of its circular related to the Entrusted Products Related Framework Agreement, extending the date to on or before November 20, 2024. This postponement allows more time to prepare and finalize vital information for shareholders. Investors in LEPU ScienTech should stay informed about these developments that may impact their investment decisions.
For further insights into HK:2291 stock, check out TipRanks’ Stock Analysis page.